Patient Monitoring Devices Market By Product, End User, & Region - Global Forecast to 2031

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND START DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3.1 PATIENT MONITORING DEVICES MARKET OVERVIEW
3.2 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT AND COUNTRY (2025)
3.3 PATIENT MONITORING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
3.4 PATIENT MONITORING DEVICES MARKET, BY REGION (2024-2031)
3.5 PATIENT MONITORING DEVICES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Emergence of predictive analytics in vital sign monitors
4.2.1.2 Growing preference for wearable patient monitoring devices, biosensors, and smart implants
4.2.1.3 Availability of wireless monitoring devices
4.2.1.4 Expansion of telehealth services and remote monitoring capabilities
4.2.1.5 Growing incidence of chronic diseases
4.2.2 RESTRAINTS
4.2.2.1 Risks associated with invasive monitoring devices
4.2.2.2 High cost of patient monitoring products and inadequate reimbursement
4.2.3 OPPORTUNITIES
4.2.3.1 Integration with electronic health records (EHRs)
4.2.3.2 Expansion of remote patient monitoring in home healthcare settings
4.2.4 CHALLENGES
4.2.4.1 Lack of personnel and limited awareness & education for patient monitoring devices
4.2.4.2 Increased pricing pressure on market players
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN PATIENT MONITORING DEVICES MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL PATIENT MONITORING DEVICES INDUSTRY
5.2.4 TRENDS IN GLOBAL HEALTHCARE & MEDICAL DEVICES INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.3.1 PROMINENT COMPANIES
5.3.2 SMALL & MEDIUM-SIZED COMPANIES
5.3.3 END USERS
5.4 VALUE CHAIN ANALYSIS
5.4.1 RESEARCH & DEVELOPMENT
5.4.2 PROCUREMENT AND PRODUCT DEVELOPMENT
5.4.3 MARKETING, SALES, DISTRIBUTION, AND POST-SALES SERVICES
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
5.6.1 AVERAGE SELLING PRICE, BY PRODUCT (2025)
5.6.2 AVERAGE SELLING PRICE, BY REGION (2025)
5.7 TRADE ANALYSIS
5.7.1 IMPORT SCENARIO (HS CODE 9018)
5.7.2 EXPORT DATA (HS CODE 9018)
5.8 KEY CONFERENCES AND EVENTS, 2026-2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10 INVESTMENT AND FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
5.11.1 CASE STUDY 1: SCALING REMOTE CARDIAC MONITORING
5.11.2 CASE STUDY 2: IMPROVING CHRONIC DISEASE MANAGEMENT THROUGH RPM
5.11.3 CASE STUDY 3: ENHANCING PATIENT SURVEILLANCE IN ACUTE CARE SETTINGS
5.12 IMPACT OF US TARIFFS - PATIENT MONITORING DEVICES MARKET
5.12.1 INTRODUCTION
5.12.2 KEY TARIFF RATES
5.12.3 PRICE IMPACT ANALYSIS
5.12.4 IMPACT ON COUNTRIES/REGIONS
5.12.4.1 North America
5.12.4.2 Europe
5.12.4.3 Asia Pacific
5.12.5 IMPACT ON END-USE INDUSTRIES

6.1 KEY EMERGING TECHNOLOGIES
6.1.1 SMART WEARABLE MONITORING DEVICES
6.1.2 VITAL SIGN MONITORS
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 REMOTE PATIENT MONITORS
6.2.2 AI & IOT
6.3 TECHNOLOGY/PRODUCT ROADMAP
6.3.1 SHORT-TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
6.3.2 MID-TERM (2027-2030) | EXPANSION & STANDARDIZATION
6.3.3 LONG-TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
6.4 PATENT ANALYSIS
6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.5 FUTURE APPLICATIONS
6.5.1 AI-ENABLED REMOTE PATIENT MONITORING & PREDICTIVE HEALTH ANALYTICS
6.5.2 HOME-BASED CHRONIC DISEASE MANAGEMENT & TELEHEALTH INTEGRATION
6.5.3 SMART HOSPITALS & INTEGRATED CLINICAL MONITORING NETWORKS
6.6 IMPACT OF AI/GEN AI ON PATIENT MONITORING DEVICES MARKET
6.6.1 TOP USE CASES AND MARKET POTENTIAL
6.6.2 CASE STUDIES OF AI IMPLEMENTATION IN PATIENT MONITORING DEVICES MARKET
6.6.3 INTERCONNECTED/ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
6.6.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PATIENT MONITORING DEVICES MARKET

7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2 INDUSTRY STANDARDS

8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 KEY BUYING CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY
8.5.1 REVENUE POTENTIAL
8.5.2 COST DYNAMICS
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS

9.1 INTRODUCTION
9.2 BLOOD GLUCOSE MONITORING DEVICES
9.2.1 SELF-MONITORING BLOOD GLUCOSE DEVICES
9.2.1.1 Rising adoption of integrated glucose monitoring devices to drive growth
9.2.2 CONTINUOUS GLUCOSE MONITORING DEVICES
9.2.2.1 Product launches and evolving reimbursement scenarios for continuous monitoring devices to drive market growth
9.2.3 WEARABLE GLUCOSE MONITORING DEVICES
9.2.3.1 Growing patient inclination towards wearable monitors to boost the market
9.3 CARDIAC MONITORING DEVICES
9.3.1 ECG DEVICES
9.3.1.1 Low cost and wide applications of ECG devices to drive market growth
9.3.2 IMPLANTABLE LOOP RECORDERS
9.3.2.1 High cost and limited applications to limit growth
9.3.3 EVENT MONITORS
9.3.3.1 Emergence of portable and wireless event monitors to drive market growth
9.3.4 MCT MONITORS
9.3.4.1 Availability of alternate technologies to hinder market growth
9.3.5 SMART/WEARABLE ECG MONITORS
9.3.5.1 Need to minimize treatment costs for CVD patients to increase adoption of smart/wearable ECG monitors
9.4 MULTIPARAMETER MONITORING DEVICES
9.4.1 LOW-ACUITY MONITORS
9.4.1.1 Increasing adoption of low-acuity monitors in general wards to drive market growth
9.4.2 MID-ACUITY MONITORS
9.4.2.1 Rising geriatric population to increase market growth
9.4.3 HIGH-ACUITY MONITORS
9.4.3.1 Increasing partnerships between manufacturers and hospitals & clinics to drive device sales
9.5 RESPIRATORY MONITORING DEVICES
9.5.1 PULSE OXIMETERS
9.5.1.1 Rising adoption of pulse oximeters in home care settings to drive market growth
9.5.2 SPIROMETERS
9.5.2.1 Technological advancements to increase adoption of spirometers
9.5.3 CAPNOGRAPHS
9.5.3.1 Product development and growing commercial acceptance to drive market growth
9.5.4 PEAK FLOW METERS
9.5.4.1 Low preference for peak flow meters due to high variability in measurements from different devices, to hinder market growth
9.6 TEMPERATURE MONITORING DEVICES
9.6.1 HANDHELD TEMPERATURE MONITORING DEVICES
9.6.1.1 Advantages associated with handheld temperature monitoring devices to drive market growth
9.6.2 TABLE-TOP TEMPERATURE MONITORING DEVICES
9.6.2.1 Increasing risks associated with hypothermia during surgeries to drive demand for table-top devices
9.6.3 WEARABLE CONTINUOUS MONITORING DEVICES
9.6.3.1 Versatile functionalities offered by wearable continuous monitoring devices to drive demand
9.6.4 INVASIVE TEMPERATURE MONITORING DEVICES
9.6.4.1 Risk of bloodstream infections associated with catheter usage to hinder market for invasive devices
9.6.5 SMART TEMPERATURE MONITORING PATCHES
9.6.5.1 Long-term monitoring capabilities of smart patches to drive market growth
9.7 HEMODYNAMIC/PRESSURE MONITORING DEVICES
9.7.1 HEMODYNAMIC MONITORS
9.7.1.1 Influx of VC funding to drive market growth
9.7.2 BLOOD PRESSURE MONITORS
9.7.2.1 Development of wearable blood pressure monitors to drive market growth
9.7.3 DISPOSABLES
9.7.3.1 Growing number of surgical procedures to drive growth in disposables market
9.8 FETAL & NEONATAL MONITORING DEVICES
9.8.1 FETAL MONITORING DEVICES
9.8.1.1 Rising prevalence of obstetric complications to drive market growth
9.8.2 NEONATAL MONITORING DEVICES
9.8.2.1 Rising number of neonatal care facilities worldwide to drive market
9.9 NEUROMONITORING DEVICES
9.9.1 EEG MACHINES
9.9.1.1 Growing applications and technological advancements to favor market growth
9.9.2 EMG MACHINES
9.9.2.1 Availability of reimbursements for EMG-assisted surgeries to boost product demand
9.9.3 CEREBRAL OXIMETERS
9.9.3.1 Growing cases of hypoxia during surgical procedures to drive market growth
9.9.4 ICP MONITORS
9.9.4.1 Growing incidence of post-surgical cerebrovascular complications and TBIs to support adoption of ICP monitors
9.9.5 MEG MACHINES
9.9.5.1 High implementation and maintenance costs of MEG devices hinder market growth
9.9.6 TCD MACHINES
9.9.6.1 Rising prevalence of strokes and cerebrovascular disorders to contribute to market growth
9.10 WEIGHT MONITORING DEVICES
9.10.1 DIGITAL WEIGHT MONITORING DEVICES
9.10.1.1 Consumer preference for digital scales - a key market driver
9.10.2 ANALOG WEIGHT MONITORING DEVICES
9.10.2.1 Rising prevalence of obesity and low cost of analog scales to support market growth
9.11 OTHER PATIENT MONITORING DEVICES

10.1 INTRODUCTION
10.2 HOSPITALS & CLINICS
10.2.1 ABILITY TO AFFORD HIGH INSTALLATION & MAINTENANCE COSTS OF PATIENT MONITORING TECHNOLOGIES TO BOOST MARKET
10.3 AMBULATORY SURGICAL CENTERS
10.3.1 COST-EFFECTIVENESS AND CONVENIENCE TO DRIVE DEMAND FOR AMBULATORY CARE
10.4 HOME CARE SETTINGS
10.4.1 REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH
10.5 OTHER END USERS

11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 Growing number of FDA approvals for patient monitoring devices to support market growth
11.2.2 CANADA
11.2.2.1 Growing public-private funding for research to drive market growth
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth
11.3.2 UK
11.3.2.1 Increasing public & private investments to contribute to market growth
11.3.3 FRANCE
11.3.3.1 Statutory health insurance system to support market growth
11.3.4 ITALY
11.3.4.1 Rising incidence of lifestyle diseases to drive adoption of patient monitoring devices
11.3.5 SPAIN
11.3.5.1 Growing number of surgical procedures to drive market growth in Spain
11.3.6 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 JAPAN
11.4.1.1 Large geriatric population and favorable reimbursement scenario to support market growth
11.4.2 CHINA
11.4.2.1 Growing focus of local and international market players to favor market growth
11.4.3 INDIA
11.4.3.1 Increasing government-implemented healthcare initiatives to support market growth
11.4.4 AUSTRALIA
11.4.4.1 R&D tax incentive program to support market growth
11.4.5 SOUTH KOREA
11.4.5.1 Supportive government initiatives to drive market growth
11.4.6 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 BRAZIL
11.5.1.1 Brazil to dominate LATAM market
11.5.2 MEXICO
11.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
11.5.3 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF PATIENT MONITORING DEVICES
11.7 GCC COUNTRIES
11.7.1 HEALTHCARE DIGITALIZATION INITIATIVES TO ACCELERATE PATIENT MONITORING DEVICE ADOPTION IN GCC

12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
12.3 REVENUE ANALYSIS
12.4 MARKET SHARE ANALYSIS
12.4.1 GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
12.4.2 GLOBAL CARDIAC MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
12.4.3 GLOBAL MULTIPARAMETER MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
12.4.4 GLOBAL HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
12.4.5 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Product footprint
12.5.5.4 End-user footprint
12.6 COMPETITIVE EVALUATION MATRIX: STARTUPS/SMES, 2025
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
12.6.5.1 Detailed list of key startups/SMEs
12.6.5.2 Competitive benchmarking of key startups/SMEs, 2025
12.7 COMPANY VALUATION & FINANCIAL METRICS
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES & APPROVALS
12.9.2 DEALS
12.9.3 EXPANSIONS

13.1 KEY PLAYERS
13.1.1 MEDTRONIC
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Product launches & approvals
13.1.1.3.2 Deals
13.1.1.4 The Analyst's View
13.1.1.4.1 Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 ABBOTT LABORATORIES
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.3.1 Product launches & approvals
13.1.2.3.2 Deals
13.1.2.4 The Analyst's View
13.1.2.4.1 Right to win
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 DEXCOM, INC.
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 Recent developments
13.1.3.3.1 Product launches & approvals
13.1.3.3.2 Deals
13.1.3.4 The Analyst's View
13.1.3.4.1 Right to win
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses & competitive threats
13.1.4 GE HEALTHCARE
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.4.3 Recent developments
13.1.4.3.1 Product launches & approvals
13.1.4.3.2 Deals
13.1.4.4 The Analyst's View
13.1.4.4.1 Right to win
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses & competitive threats
13.1.5 PHILIPS HEALTHCARE
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 Recent developments
13.1.5.3.1 Product launches & approvals
13.1.5.3.2 Deals
13.1.5.4 The Analyst's View
13.1.5.4.1 Right to win
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses & competitive threats
13.1.6 NIHON KOHDEN CORPORATION
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.6.3 Recent developments
13.1.6.3.1 Product launches & approvals
13.1.6.3.2 Deals
13.1.7 MINDRAY MEDICAL INTERNATIONAL LTD.
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.7.3 Recent developments
13.1.7.3.1 Product launches & approvals
13.1.7.3.2 Deals
13.1.8 BD
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.9 GETINGE AB
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.9.3 Recent developments
13.1.9.3.1 Product launches, enhancements, and approvals
13.1.9.3.2 Deals
13.1.10 BAXTER INTERNATIONAL (HILL-ROM HOLDINGS, INC.)
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.11 DRÄGERWERK AG & CO. KGAA
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.12 BOSTON SCIENTIFIC CORPORATION
13.1.12.1 Business overview
13.1.12.2 Products offered
13.1.12.3 Recent developments
13.1.12.3.1 Deals
13.1.13 MASIMO CORPORATION
13.1.13.1 Business overview
13.1.13.2 Products offered
13.1.14 OMRON CORPORATION
13.1.14.1 Business overview
13.1.14.2 Products offered
13.1.15 ARCHIMED SAS (NATUS MEDICAL)
13.1.15.1 Business overview
13.1.15.2 Products offered
13.1.15.3 Recent developments
13.1.15.3.1 Deals
13.1.16 COMPUMEDICS LIMITED
13.1.16.1 Business overview
13.1.16.2 Products offered
13.1.16.3 Recent developments
13.1.16.3.1 Deals
13.1.17 NONIN MEDICAL, INC.
13.1.17.1 Business overview
13.1.17.2 Products offered
13.1.17.3 Recent developments
13.1.17.3.1 Product launches & approvals
13.2 OTHER PLAYERS
13.2.1 BIOTRONIK
13.2.2 SCHILLER AG
13.2.3 SENSEONICS
13.2.4 CARDIOMO
13.2.5 VITLS
13.2.6 NETEERA
13.2.7 QARDIO
13.2.8 VIVIFY HEALTH
13.2.9 IRHYTHM TECHNOLOGIES, INC.
13.2.10 OSYPKA MEDICAL
13.2.11 CARDINAL HEALTH
13.2.12 MERIT MEDICAL SYSTEMS

14.1 RESEARCH DATA
14.1.1 SECONDARY DATA
14.1.1.1 Key data from secondary sources
14.1.2 PRIMARY DATA
14.1.2.1 Key data from primary sources
14.1.2.2 Key industry insights
14.2 MARKET SIZE ESTIMATION
14.3 MARKET BREAKDOWN AND DATA TRIANGULATION
14.4 MARKET SHARE ESTIMATION
14.5 STUDY ASSUMPTIONS
14.6 METHODOLOGY-RELATED LIMITATIONS
14.7 RESEARCH LIMITATIONS
14.8 RISK ASSESSMENT

15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: THE SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS

TABLE 1 STANDARD CURRENCY CONVERSION RATES TO USD
TABLE 2 PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 3 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021-2030
TABLE 4 AVERAGE SELLING PRICE OF PATIENT MONITORING DEVICES, BY KEY PLAYER, 2025 (USD)
TABLE 5 AVERAGE SELLING PRICE OF PATIENT MONITORING DEVICES, BY REGION, 2025 (USD)
TABLE 6 IMPORT DATA FOR PATIENT MONITORING DEVICES PRODUCTS UNDER HS CODE 9018, BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 7 EXPORT DATA FOR PATIENT MONITORING DEVICES UNDER HS CODE 9018, BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 8 PATIENT MONITORING DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS (2026-2027)
TABLE 9 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 10 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR PATIENT MONITORING DEVICES
TABLE 11 TOP USE CASES AND MARKET POTENTIAL
TABLE 12 PATIENT MONITORING DEVICES MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION
TABLE 13 INTERCONNECTED/ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 GLOBAL STANDARDS IN PATIENT MONITORING DEVICES MARKET
TABLE 20 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PATIENT MONITORING DEVICES
TABLE 21 KEY BUYING CRITERIA FOR PATIENT MONITORING DEVICES
TABLE 22 PATIENT MONITORING DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS
TABLE 23 PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 24 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 25 BLOOD GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 26 PATIENT MONITORING DEVICES MARKET VOLUME FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
TABLE 27 SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 28 CONTINUOUS GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 29 WEARABLE GLUCOSE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 30 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 31 CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 32 PATIENT MONITORING DEVICES MARKET VOLUME FOR CARDIAC MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
TABLE 33 ECG DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 34 IMPLANTABLE LOOP RECORDERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 35 EVENT MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 36 MCT MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 37 SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS
TABLE 38 SMART/WEARABLE ECG MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 39 MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 40 MULTIPARAMETER MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 41 PATIENT MONITORING DEVICES MARKET VOLUME FOR MULTI-PARAMETER MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
TABLE 42 LOW-ACUITY MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 43 MID-ACUITY MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 44 HIGH-ACUITY MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 45 RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 46 RESPIRATORY MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 47 PATIENT MONITORING DEVICES MARKET VOLUME FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
TABLE 48 PULSE OXIMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 49 SPIROMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 50 CAPNOGRAPHS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 51 PEAK FLOW METERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 52 TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 53 TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 54 PATIENT MONITORING DEVICES MARKET VOLUME FOR TEMPERATURE MONITORING SYSTEMS, BY REGION, 2024-2031 (UNITS)
TABLE 55 HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS
TABLE 56 HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 57 TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 58 WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS
TABLE 59 WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 60 INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 61 SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS
TABLE 62 SMART TEMPERATURE MONITORING PATCHES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 63 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 64 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 65 PATIENT MONITORING DEVICES MARKET VOLUME FOR HEMODYNAMIC/ PRESSURE MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
TABLE 66 HEMODYNAMIC MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 67 WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS
TABLE 68 BLOOD PRESSURE MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 69 HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 70 FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 71 FETAL & NEONATAL MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 72 PATIENT MONITORING DEVICES MARKET VOLUME FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
TABLE 73 WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY MARKET PLAYERS
TABLE 74 FETAL MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 75 NEONATAL MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 76 NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 77 NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 78 PATIENT MONITORING DEVICES MARKET VOLUME FOR NEUROMONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
TABLE 79 EEG MACHINES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 80 EMG MACHINES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 81 CEREBRAL OXIMETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 82 ICP MONITORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 83 MEG MACHINES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 84 TCD MACHINES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 85 WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 86 WEIGHT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 87 PATIENT MONITORING DEVICES MARKET VOLUME FOR WEIGHT MONITORING DEVICES, BY REGION, 2024-2031 (UNITS)
TABLE 88 DIGITAL WEIGHT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 89 ANALOG WEIGHT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 90 POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS
TABLE 91 WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS
TABLE 92 OTHER PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 93 PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 94 PATIENT MONITORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 95 PATIENT MONITORING DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 96 PATIENT MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 97 PATIENT MONITORING DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 98 PATIENT MONITORING DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 99 PATIENT MONITORING DEVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 100 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 101 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 102 NORTH AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 103 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 104 NORTH AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 105 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 106 NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 107 NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 108 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 109 NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 110 NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 111 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 112 US: VC FUNDING IN PATIENT MONITORING DEVICES MARKET
TABLE 113 US: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 114 US: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 115 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 116 US: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 117 US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 118 US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 119 US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 120 US: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 121 US: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 122 US: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 123 US: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 124 RESEARCH GRANTS IN PATIENT MONITORING DEVICES MARKET IN CANADA
TABLE 125 RECENT DEVELOPMENTS IN CANADIAN PATIENT MONITORING DEVICES MARKET
TABLE 126 CANADA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 127 CANADA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 128 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 129 CANADA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 130 CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 131 CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 132 CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 133 CANADA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 134 CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 135 CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 136 CANADA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 137 PRODUCT APPROVALS IN EUROPEAN PATIENT MONITORING DEVICES MARKET
TABLE 138 EUROPE: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 139 EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 140 EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 141 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 142 EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 143 EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 144 EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 145 EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 146 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 147 EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 148 EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 149 EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 150 GERMANY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 151 GERMANY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 152 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 153 GERMANY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 154 GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 155 GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 156 GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 157 GERMANY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 158 GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 159 GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 160 GERMANY: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 161 UK: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 162 UK: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 163 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 164 UK: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 165 UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 166 UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 167 UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 168 UK: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 169 UK: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 170 UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 171 UK: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 172 FRANCE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 173 FRANCE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 174 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 175 FRANCE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 176 FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 177 FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 178 FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 179 FRANCE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 180 FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 181 FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 182 FRANCE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 183 ITALY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 184 ITALY: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 185 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 186 ITALY: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 187 ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 188 ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 189 ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 190 ITALY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 191 ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 192 ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 193 ITALY: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 194 SPAIN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 195 SPAIN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 196 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 197 SPAIN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 198 SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 199 SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 200 SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 201 SPAIN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 202 SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 203 SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 204 SPAIN: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 205 REST OF EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 206 REST OF EUROPE: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 207 REST OF EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 208 REST OF EUROPE: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 209 REST OF EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 210 REST OF EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 211 REST OF EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 212 REST OF EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 213 REST OF EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 214 REST OF EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 215 REST OF EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 216 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 217 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 218 ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 219 ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 220 ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 221 ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 222 ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 223 ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 224 ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 225 ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 226 ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 227 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 228 JAPAN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 229 JAPAN: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 230 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 231 JAPAN: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 232 JAPAN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 233 JAPAN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 234 JAPAN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 235 JAPAN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 236 JAPAN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 237 JAPAN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 238 JAPAN: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 239 CHINA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 240 CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 241 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 242 CHINA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 243 CHINA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 244 CHINA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 245 CHINA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 246 CHINA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 247 CHINA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 248 CHINA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 249 CHINA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 250 INDIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 251 INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 252 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 253 INDIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 254 INDIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 255 INDIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 256 INDIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 257 INDIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 258 INDIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 259 INDIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 260 INDIA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 261 AUSTRALIA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 262 AUSTRALIA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 263 AUSTRALIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 264 AUSTRALIA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 265 AUSTRALIA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 266 AUSTRALIA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 267 AUSTRALIA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 268 AUSTRALIA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 269 AUSTRALIA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 270 AUSTRALIA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 271 AUSTRALIA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 272 SOUTH KOREA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 273 SOUTH KOREA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 274 SOUTH KOREA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 275 SOUTH KOREA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 276 SOUTH KOREA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 277 SOUTH KOREA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 278 SOUTH KOREA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 279 SOUTH KOREA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 280 SOUTH KOREA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 281 SOUTH KOREA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 282 SOUTH KOREA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 283 REST OF ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 284 REST OF ASIA PACIFIC: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 285 REST OF ASIA PACIFIC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 286 REST OF ASIA PACIFIC: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 287 REST OF ASIA PACIFIC: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 288 REST OF ASIA PACIFIC: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 289 REST OF ASIA PACIFIC: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 290 REST OF ASIA PACIFIC: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 291 REST OF ASIA PACIFIC: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 292 REST OF ASIA PACIFIC: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 293 REST OF ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 294 LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 295 LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 296 LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 297 LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 298 LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 299 LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 300 LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 301 LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 302 LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 303 LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 304 LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 305 LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 306 BRAZIL: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 307 BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 308 BRAZIL: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 309 BRAZIL: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 310 BRAZIL: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 311 BRAZIL: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 312 BRAZIL: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 313 BRAZIL: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 314 BRAZIL: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 315 BRAZIL: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 316 BRAZIL: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 317 MEXICO: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 318 MEXICO: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 319 MEXICO: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 320 MEXICO: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 321 MEXICO: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 322 MEXICO: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 323 MEXICO: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 324 MEXICO: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 325 MEXICO: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 326 MEXICO: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 327 MEXICO: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 328 REST OF LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 329 REST OF LATIN AMERICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 330 REST OF LATIN AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 331 REST OF LATIN AMERICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 332 REST OF LATIN AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 333 REST OF LATIN AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 334 REST OF LATIN AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 335 REST OF LATIN AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 336 REST OF LATIN AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 337 REST OF LATIN AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 338 REST OF LATIN AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 339 MIDDLE EAST & AFRICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 340 MIDDLE EAST & AFRICA: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 341 MIDDLE EAST & AFRICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 342 MIDDLE EAST & AFRICA: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 343 MIDDLE EAST & AFRICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 344 MIDDLE EAST & AFRICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 345 MIDDLE EAST & AFRICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 346 MIDDLE EAST & AFRICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 347 MIDDLE EAST & AFRICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 348 MIDDLE EAST & AFRICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 349 MIDDLE EAST & AFRICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 350 GCC COUNTRIES: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 351 GCC COUNTRIES: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 352 GCC COUNTRIES: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 353 GCC COUNTRIES: MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 354 GCC COUNTRIES: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 355 GCC COUNTRIES: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 356 GCC COUNTRIES: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 357 GCC COUNTRIES: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 358 GCC COUNTRIES: NEUROMONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 359 GCC COUNTRIES: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 360 GCC COUNTRIES: PATIENT MONITORING DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 361 KEY DEVELOPMENTS IN PATIENT MONITORING DEVICES MARKET, JANUARY 2022-JUNE 2026
TABLE 362 PATIENT MONITORING MARKET: DEGREE OF COMPETITION
TABLE 363 PATIENT MONITORING DEVICES MARKET: REGION FOOTPRINT (17 COMPANIES)
TABLE 364 PATIENT MONITORING DEVICES MARKET: PRODUCT FOOTPRINT (17 COMPANIES)
TABLE 365 PATIENT MONITORING DEVICES MARKET: END-USER FOOTPRINT (17 COMPANIES)
TABLE 366 PATIENT MONITORING DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 367 PATIENT MONITORING DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, 2025
TABLE 368 PATIENT MONITORING DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-JANUARY 2026
TABLE 369 PATIENT MONITORING DEVICES MARKET: DEALS, JANUARY 2022-JANUARY 2026
TABLE 370 PATIENT MONITORING DEVICES MARKET: EXPANSIONS, JANUARY 2022-JANUARY 2026
TABLE 371 MEDTRONIC: COMPANY OVERVIEW
TABLE 372 MEDTRONIC PLC: PRODUCTS OFFERED
TABLE 373 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS
TABLE 374 MEDTRONIC PLC: DEALS
TABLE 375 ABBOTT LABORATORIES: COMPANY OVERVIEW
TABLE 376 ABBOTT LABORATORIES: PRODUCTS OFFERED
TABLE 377 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS
TABLE 378 ABBOTT LABORATORIES: DEALS
TABLE 379 DEXCOM, INC.: COMPANY OVERVIEW
TABLE 380 DEXCOM, INC.: PRODUCTS OFFERED
TABLE 381 DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS
TABLE 382 DEXCOM, INC.: DEALS
TABLE 383 GE HEALTHCARE: COMPANY OVERVIEW
TABLE 384 GE HEALTHCARE: PRODUCTS OFFERED
TABLE 385 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS
TABLE 386 GE HEALTHCARE: DEALS
TABLE 387 PHILIPS HEALTHCARE: COMPANY OVERVIEW
TABLE 388 PHILIPS HEALTHCARE: PRODUCTS OFFERED
TABLE 389 PHILIPS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS
TABLE 390 PHILIPS HEALTHCARE: DEALS
TABLE 391 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
TABLE 392 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
TABLE 393 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS
TABLE 394 NIHON KOHDEN CORPORATION: DEALS
TABLE 395 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY OVERVIEW
TABLE 396 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCTS OFFERED
TABLE 397 MINDRAY MEDICAL INTERNATIONAL LTD.: PRODUCT LAUNCHES & APPROVALS
TABLE 398 MINDRAY MEDICAL INTERNATIONAL LTD.: DEALS
TABLE 399 BD: COMPANY OVERVIEW
TABLE 400 BD: PRODUCTS OFFERED
TABLE 401 GETINGE AB: COMPANY OVERVIEW
TABLE 402 GETINGE AB: PRODUCTS OFFERED
TABLE 403 GETTING AB: PRODUCT ENHANCEMENTS, AND APPROVALS
TABLE 404 GETTING AB: DEALS
TABLE 405 BAXTER INTERNATIONAL: COMPANY OVERVIEW
TABLE 406 BAXTER INTERNATIONAL: PRODUCTS OFFERED
TABLE 407 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW
TABLE 408 DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED
TABLE 409 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 410 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 411 BOSTON SCIENTIFIC CORPORATION: DEALS
TABLE 412 MASIMO CORPORATION: COMPANY OVERVIEW
TABLE 413 MASIMO CORPORATION: PRODUCTS OFFERED
TABLE 414 OMRON CORPORATION: COMPANY OVERVIEW
TABLE 415 OMRON CORPORATION: PRODUCTS OFFERED
TABLE 416 ARCHIMED SAS: BUSINESS OVERVIEW
TABLE 417 ARCHIMED SAS (NATUS MEDICAL): PRODUCTS OFFERED
TABLE 418 ARCHIMED SAS (NATUS MEDICAL): DEALS
TABLE 419 COMPUMEDICS LIMITED: BUSINESS OVERVIEW
TABLE 420 COMPUMEDICS LIMITED: PRODUCTS OFFERED
TABLE 421 COMPUMEDICS LIMITED: DEALS
TABLE 422 NONIN MEDICAL, INC.: BUSINESS OVERVIEW
TABLE 423 NONIN MEDICAL, INC.: PRODUCTS OFFERED
TABLE 424 NONIN MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS
TABLE 425 RISK ASSESSMENT: PATIENT MONITORING DEVICES

FIGURE 1 PATIENT MONITORING DEVICES MARKET SEGMENTATION
FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS
FIGURE 3 PATIENT MONITORING DEVICES MARKET, 2026-2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT MONITORING DEVICES MARKET
FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF PATIENT MONITORING DEVICES MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN PATIENT MONITORING DEVICES MARKET, 2026
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 8 STRINGENT REGULATORY FRAMEWORK IN BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH
FIGURE 9 HOSPITAL & CLINICS FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2025
FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE FROM 2026 TO 2031
FIGURE 11 NORTH AMERICA TO HOLD LARGEST MARKET SHARE TILL 2031
FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE
FIGURE 13 PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 PATIENT MONITORING DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 15 PATIENT MONITORING MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 16 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
FIGURE 17 PATIENT MONITORING DEVICES MARKET: ECOSYSTEM ANALYSIS
FIGURE 18 PATIENT MONITORING DEVICES MARKET: TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES
FIGURE 19 PATIENT MONITORING DEVICES MARKET: INVESTMENT & FUNDING SCENARIO
FIGURE 20 NUMBER OF PATENTS PUBLISHED (JANUARY 2016-JUNE 2026)
FIGURE 21 TOP APPLICANT COUNTRIES/REGIONS FOR PATIENT MONITORING DEVICES (JANUARY 2016- JUNE 2026)
FIGURE 22 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PATIENT MONITORING DEVICES
FIGURE 23 KEY BUYING CRITERIA FOR PATIENT MONITORING DEVICES
FIGURE 24 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET SNAPSHOT
FIGURE 25 ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET SNAPSHOT
FIGURE 26 REVENUE ANALYSIS OF TOP PLAYERS IN PATIENT MONITORING DEVICES MARKET, 2021-2025 (USD MILLION)
FIGURE 27 BLOOD GLUCOSE MONITORING DEVICES MARKET SHARE ANALYSIS, 2025
FIGURE 28 CARDIAC MONITORING DEVICES MARKET SHARE ANALYSIS, 2025
FIGURE 29 MULTIPARAMETER MONITORING DEVICES MARKET SHARE ANALYSIS, 2023
FIGURE 30 HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET SHARE ANALYSIS, 2025
FIGURE 31 FETAL & NEONATAL MONITORING DEVICES MARKET SHARE ANALYSIS, 2025
FIGURE 32 PATIENT MONITORING DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 33 PATIENT MONITORING DEVICES MARKET: COMPANY FOOTPRINT
FIGURE 34 PATIENT MONITORING DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 35 EV/EBITDA OF KEY VENDORS
FIGURE 36 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 37 PATIENT MONITORING DEVICES MARKET: BRAND/PRODUCT COMPARISON
FIGURE 38 MEDTRONIC: COMPANY SNAPSHOT
FIGURE 39 ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 40 DEXCOM, INC.: COMPANY SNAPSHOT
FIGURE 41 GE HEALTHCARE: COMPANY SNAPSHOT
FIGURE 42 PHILIPS HEALTHCARE: COMPANY SNAPSHOT
FIGURE 43 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
FIGURE 44 MINDRAY MEDICAL INTERNATIONAL LTD.: COMPANY SNAPSHOT
FIGURE 45 BD: COMPANY SNAPSHOT
FIGURE 46 GETINGE AB.: COMPANY SNAPSHOT
FIGURE 47 BAXTER INTERNATIONAL: COMPANY SNAPSHOT
FIGURE 48 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT
FIGURE 49 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
FIGURE 50 MASIMO CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 51 OMRON CORPORATION: COMPANY SNAPSHOT
FIGURE 52 COMPUMEDICS LIMITED: COMPANY SNAPSHOT
FIGURE 53 RESEARCH DESIGN
FIGURE 54 PRIMARY SOURCES
FIGURE 55 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY/DEMAND-SIDE PARTICIPANTS
FIGURE 56 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 57 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
FIGURE 58 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC
FIGURE 59 SUPPLY-SIDE ANALYSIS OF TOP COMPANIES (2025)
FIGURE 60 PATIENT MONITORING DEVICES MARKET: CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2031)
FIGURE 61 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 62 DATA TRIANGULATION METHODOLOGY